Literature DB >> 29570931

Uveal melanoma driver mutations in GNAQ/11 yield numerous changes in melanocyte biology.

Dahlia E Perez1, Andrea M Henle1,2, Adam Amsterdam1, Hannah R Hagen1, Jacqueline A Lees1.   

Abstract

Uveal melanoma (UM) is the most common primary intraocular cancer and has a high incidence of metastasis, which lacks any effective treatment. Here, we present zebrafish models of UM, which are driven by melanocyte-specific expression of activating GNAQ or GNA11 alleles, GNAQ/11Q209L , the predominant initiating mutations for human UM. When combined with mutant tp53, GNAQ/11Q209L transgenics develop various melanocytic tumors, including UM, with near complete penetrance. These tumors display nuclear YAP localization and thus phenocopy human UM. We show that GNAQ/11Q209L expression induces profound melanocyte defects independent of tp53 mutation, which are apparent within 3 days of development. First, increases in melanocyte number, melanin content, and subcellular melanin distribution result in hyperpigmentation. Additionally, altered melanocyte migration, survival properties, and evasion of normal boundary cues lead to aberrant melanocyte localization and stripe patterning. Collectively, these data show that GNAQ/11Q209L is sufficient to induce numerous protumorigenic changes within melanocytes.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990GNA11zzm321990; zzm321990GNAQzzm321990; melanocyte; melanophore; uveal melanoma; zebrafish

Mesh:

Substances:

Year:  2018        PMID: 29570931      PMCID: PMC6151293          DOI: 10.1111/pcmr.12700

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN: 1755-1471            Impact factor:   4.693


  31 in total

1.  Embryonic requirements for ErbB signaling in neural crest development and adult pigment pattern formation.

Authors:  Erine H Budi; Larissa B Patterson; David M Parichy
Journal:  Development       Date:  2008-05-28       Impact factor: 6.868

2.  The deficiency of Gαq leads to enhanced T-cell survival.

Authors:  Dashan Wang; Yugao Zhang; Yan He; Yan Li; Frances E Lund; Guixiu Shi
Journal:  Immunol Cell Biol       Date:  2014-06-24       Impact factor: 5.126

Review 3.  Ocular melanoma: an overview of the current status.

Authors:  Predrag Jovanovic; Marija Mihajlovic; Jasmina Djordjevic-Jocic; Slobodan Vlajkovic; Sonja Cekic; Vladisav Stefanovic
Journal:  Int J Clin Exp Pathol       Date:  2013-06-15

4.  Oncogenic G Protein GNAQ Induces Uveal Melanoma and Intravasation in Mice.

Authors:  Jenny Li-Ying Huang; Oscar Urtatiz; Catherine D Van Raamsdonk
Journal:  Cancer Res       Date:  2015-06-25       Impact factor: 12.701

5.  Protein kinase C inhibitor AEB071 targets ocular melanoma harboring GNAQ mutations via effects on the PKC/Erk1/2 and PKC/NF-κB pathways.

Authors:  Xinqi Wu; Jingjing Li; Meijun Zhu; Jonathan A Fletcher; F Stephen Hodi
Journal:  Mol Cancer Ther       Date:  2012-05-31       Impact factor: 6.261

6.  Detection of GNAQ mutations and reduction of cell viability in uveal melanoma cells with functionalized gold nanoparticles.

Authors:  Christian Posch; Alfonso Latorre; Michelle B Crosby; Anna Celli; Ana Latorre; Igor Vujic; Martina Sanlorenzo; Gary A Green; Jingly Weier; Mitchell Zekhtser; Jeffrey Ma; Gabriela Monico; Devron H Char; Denis Jusufbegovic; Klemens Rappersberger; Álvaro Somoza; Susana Ortiz-Urda
Journal:  Biomed Microdevices       Date:  2015-02       Impact factor: 2.838

Review 7.  GNAQ and GNA11 mutations in uveal melanoma.

Authors:  Alexander N Shoushtari; Richard D Carvajal
Journal:  Melanoma Res       Date:  2014-12       Impact factor: 3.599

8.  Lack of BRAF mutations in uveal melanoma.

Authors:  Donata Rimoldi; Suzanne Salvi; Danielle Liénard; Ferdy J Lejeune; Daniel Speiser; Leonidas Zografos; Jean-Charles Cerottini
Journal:  Cancer Res       Date:  2003-09-15       Impact factor: 12.701

9.  Regulation of pigmentation in zebrafish melanophores.

Authors:  Darren W Logan; Sally F Burn; Ian J Jackson
Journal:  Pigment Cell Res       Date:  2006-06

10.  Post-embryonic nerve-associated precursors to adult pigment cells: genetic requirements and dynamics of morphogenesis and differentiation.

Authors:  Erine H Budi; Larissa B Patterson; David M Parichy
Journal:  PLoS Genet       Date:  2011-05-19       Impact factor: 5.917

View more
  11 in total

1.  Multi-omics Profiling Shows BAP1 Loss Is Associated with Upregulated Cell Adhesion Molecules in Uveal Melanoma.

Authors:  Usman Baqai; Timothy J Purwin; Nelisa Bechtel; Vivian Chua; Anna Han; Edward J Hartsough; Jeffim N Kuznetsoff; J William Harbour; Andrew E Aplin
Journal:  Mol Cancer Res       Date:  2022-08-05       Impact factor: 6.333

2.  MITF deficiency accelerates GNAQ-driven uveal melanoma.

Authors:  Grace B Phelps; Hannah R Hagen; Adam Amsterdam; Jacqueline A Lees
Journal:  Proc Natl Acad Sci U S A       Date:  2022-05-05       Impact factor: 12.779

Review 3.  Melanoma models for the next generation of therapies.

Authors:  E Elizabeth Patton; Kristen L Mueller; David J Adams; Niroshana Anandasabapathy; Andrew E Aplin; Corine Bertolotto; Marcus Bosenberg; Craig J Ceol; Christin E Burd; Ping Chi; Meenhard Herlyn; Sheri L Holmen; Florian A Karreth; Charles K Kaufman; Shaheen Khan; Sebastian Kobold; Eleonora Leucci; Carmit Levy; David B Lombard; Amanda W Lund; Kerrie L Marie; Jean-Christophe Marine; Richard Marais; Martin McMahon; Carla Daniela Robles-Espinoza; Ze'ev A Ronai; Yardena Samuels; Maria S Soengas; Jessie Villanueva; Ashani T Weeraratna; Richard M White; Iwei Yeh; Jiyue Zhu; Leonard I Zon; Marc S Hurlbert; Glenn Merlino
Journal:  Cancer Cell       Date:  2021-02-04       Impact factor: 31.743

4.  The Latest on Uveal Melanoma Research and Clinical Trials: Updates from the Cure Ocular Melanoma (CURE OM) Science Meeting (2019).

Authors:  Vivian Chua; Jane Mattei; Anna Han; Lauren Johnston; Kyleigh LiPira; Sara M Selig; Richard D Carvajal; Andrew E Aplin; Sapna P Patel
Journal:  Clin Cancer Res       Date:  2020-10-15       Impact factor: 12.531

Review 5.  Molecular Characteristics of Uveal Melanoma: Insights from the Cancer Genome Atlas (TCGA) Project.

Authors:  Mathieu F Bakhoum; Bita Esmaeli
Journal:  Cancers (Basel)       Date:  2019-07-27       Impact factor: 6.639

6.  Crosstalk with keratinocytes causes GNAQ oncogene specificity in melanoma.

Authors:  Oscar Urtatiz; Amanda Haage; Guy Tanentzapf; Catherine D Van Raamsdonk
Journal:  Elife       Date:  2021-12-23       Impact factor: 8.140

7.  Animal Models of Uveal Melanoma.

Authors:  Ogul E Uner; Nikhila Gandrakota; Corrina P Azarcon; Hans E Grossniklaus
Journal:  Ann Eye Sci       Date:  2022-03-15

Review 8.  Hindsight: Review of Preclinical Disease Models for the Development of New Treatments for Uveal Melanoma.

Authors:  Caoimhe Goldrick; Letizia Palanga; Bobby Tang; Grace Mealy; John Crown; Noel Horgan; Susan Kennedy; Naomi Walsh
Journal:  J Cancer       Date:  2021-06-04       Impact factor: 4.207

Review 9.  Update on GNA Alterations in Cancer: Implications for Uveal Melanoma Treatment.

Authors:  Lionel Larribère; Jochen Utikal
Journal:  Cancers (Basel)       Date:  2020-06-10       Impact factor: 6.639

Review 10.  Mouse models of uveal melanoma: Strengths, weaknesses, and future directions.

Authors:  Jackson R Richards; Jae Hyuk Yoo; Donghan Shin; Shannon J Odelberg
Journal:  Pigment Cell Melanoma Res       Date:  2020-01-22       Impact factor: 4.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.